Clinical Trial Update: Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC [Phase 2]

View source ↗

Summary

Phase 2 study assessing pembrolizumab alone or after targeted radiation to a lesion in previously treated patients with stage IV non-small cell lung cancer; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Keytruda (Pembrolizumab) (pembrolizumab)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Stage IV Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-05-03